लोड हो रहा है...
Bosutinib for Chronic Myeloid Leukemia
In recent years the availability of several tyrosine kinase inhibitors (TKI) in the therapeutic armamentarium for chronic myeloid leukemia has dramatically changed the objectives and expectations of healthcare providers and patients. For many, but not all, patients the forerunner of TKI, imatinib, i...
में बचाया:
| में प्रकाशित: | Rare Cancers Ther |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer Healthcare
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4837934/ https://ncbi.nlm.nih.gov/pubmed/27182477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-015-0010-y |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|